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Abstract
There has been a general increase in psychiatric symptoms since the COVID-19
pandemic began. Literature that has been published since the start of the pandemic has
indicated there is an increased risk of depression, insomnia, altered mental status, newonset psychosis, neurocognitive syndrome, and anxiety. The military veteran population
is at higher risk for psychiatric illness than the general population, and should be
screened accordingly. This quality improvement project was developed in collaboration
with the mental health clinic at urban medical center in the Midwest to identify new
symptoms of mental illness after COVID-19 diagnosis utilizing the PDSA model and
descriptive statistics. Veterans were screened via telephone for depression, anxiety,
psychosis, PTSD, and dementia utilizing the PHQ-9, GAD- 7, PCCL, PCL-5 and TMMS.
A 6% positivity rate for symptoms of new onset mental illness was found in a sample size
of 50.

Identification of Veterans Experiencing Symptoms of Mental Illness for the First
Time After COVID-19 Diagnosis
There has been a general increase in psychiatric symptoms since the COVID-19
pandemic began, and a high number of veterans at an urban Midwest medical center have
been diagnosed with COVID-19. This increase in psychiatric exacerbation falls on
several different spectrums of mental illness. Guo et al. (2020) found that direct exposure
to COVID-19 increased the risk for depression and insomnia. In a UK-wide surveillance
study that focused specifically on neurological and psychiatric complications of COVID19, altered mental status, new-onset psychosis, neurocognitive syndrome, and affective
disorders were identified (Varatharaj et al, 2020). Significant anxiety associated with the
pandemic and a positive diagnosis has led to the creation of a coronavirus-specific
anxiety scale (Lee, 2020), while case studies of new-onset psychosis while being treated
for coronavirus have been published (Boulos et al., 2020). Stigma associated with a
positive diagnosis is also affecting mental health; Gunnell et al. (2020) stress the
importance of suicide prevention during the pandemic. Brooks et al. (2020) completed a
literature review that highlighted the long-lasting psychological impact of quarantine.
These symptoms indicate a need to identify high-risk groups and intervene when
possible. Studies completed in China after the initial outbreak suggest that identification
of high-risk groups for early psychological intervention can have a positive effect (Wang
et al., 2020) and past epidemics have demonstrated that mental health sequelae can have a
longer lasting impact (Ornell et al., 2020). Increased screening has been shown to
improve access to care for patients with mental illness (Lamontagne-Godwin et al., 2018
& Webb et al., 2016). Additionally, health care advocates have the ability to influence

vulnerable individuals and identify the right type of health care (Thomas et al, 2019).
The military veteran population is at higher risk for psychiatric illness (25%) than
the general population (20.6%) (Kessler et al., 2014 & National Institute of Mental
Health, 2021), and at the time of this study, there were over 1500 veterans at the medical
center who have tested positive for COVID-19. The purpose of this project is to identify
veterans experiencing symptoms of psychiatric illness for the first time after COVID-19
diagnosis and refer them to mental health services. The Plan-Do-Study-Act model will be
utilized to guide this project. Outcomes to assess include the number of COVID-19
positive veterans with no past psychiatric history who have significant symptoms of
mental illness, the number of COVID-19 positive veterans who require a mental health
referral after screening for psychiatric symptoms, and the number of veterans who
received mental health care after referral at 3 months, including medication management
and psychotherapy at the medical center or in the community setting. The goal is to
improve care for an already high-risk patient population.
Review of Literature
A literature review (Appendix A) was conducted in July 2020 utilizing the
Summon, PsychINFO and CINAHL databases from the last 5 years. Initial terms
included “COVID-19” and “mental health.” This identified more than 107,000 articles.
The search was further refined to “symptoms,” “coronavirus,” “SARS-COV-2” and
“COVID-19 diagnosis.” This search yielded seventeen articles that met inclusion criteria.
Articles were considered for inclusion if they addressed symptoms of mental illness in
the adult population and their symptom response to COVID-19. Articles were excluded if
they only assessed the adolescent population or if they did not identify symptoms present

with a positive COVID-19 diagnosis. Limitations of this initial search include most
research has been conducted in Asia and Europe.
The increase in neuropsychiatric symptoms after a positive COVID-19 diagnosis
has been described in the literature. Reports suggest that the novel coronavirus is similar
to the SARS-CoV-1 virus in its ability to invade neurons causing delirium, psychosis, and
persistent cognitive problems (Riordan, 2020). This similarity may also affect long-term
vulnerability to neuropsychiatric effects (Riordan, 2020), including biological aspects,
which may increase vulnerability to PTSD (Horesha & Brown, 2020). Most recently, it
has been found that a COVID-19 diagnosis was associated with increase in psychiatric
illness in the following 14- 90 days (Taquet et al., 2020).
In Chinese adults with direct exposure to COVID-19, there was an increase in
depression and insomnia (Guo et al., 2020). In the United Kingdom, one in five people
with a positive COVID-19 diagnosis developed neuropsychiatric complications
(Varatharaj et al., 2020). These included new-onset psychosis, neurocognitive syndrome,
and mood affective disorders, in both younger and older populations (Varatharaj et al.,
2020). Two case studies from the United States and United Kingdom also describes newonset psychosis and delusions after COVID-19 diagnosis (Boulos et al., 2020 & Smith et
al., 2020). Another case study in China identified manic-like symptoms for the first time
after COVID-19 diagnosis (Lu et al., 2020). High levels of anxiety have also been found
in patients with COVID-19, to the extent that a Coronavirus Anxiety Scale has been
developed to assess for this (Lee, 2020). Gruber et al. (2020) found an increase in
anxiety, depression, acute stress disorder, PTSD, and substance use disorders. These

symptoms may also increase the risk of suicide, and measures should be taken to address
this (Gunnell et al., 2020).
Several studies suggest that identification of high-risk groups is necessary. In an
initial study published in February 2020, Wang et al., stress the importance of identifying
high-risk groups with the goal of earlier psychological intervention. Ornell et al. (2020)
echo this, stating that multidisciplinary mental health teams should be included to
develop these strategies to establish safe psychological counseling services. In a
longitudinal study conducted in Spain by Gonzalez-Sanguino et al. (2020), the need to
identify vulnerable groups over the course of the pandemic was identified. LamontagneGoodwin, et al., (2018) and Webb et al., (2016) found that an increase in screening
increased access to mental health services in people with mental illness and improved
outcomes. In addition, it has been found that ‘health service brokers’ or advocates are
able to identify vulnerable patients and link them to appropriate health care services
(Thomas et al., 2019). It has also been documented that Black Americans experience
higher COVID-19 rates, and PTSD rates are already higher among Black Americans
(Novacek et al., 2020). Novacek et al. (2020) recommend early identification and
treatment for PTSD for this patient population.
The psychological impact of quarantine has also been discussed in the literature.
The term “pandemic fear” has been used in the past during epidemics when talking about
the mental health side effects. Ornell et al. (2020) and Gruber et al. (2020) refer to the
defense mechanisms fear and anger during life-threatening events, the ensuing allostatic
load, and how this can contribute to the development of various psychiatric disorders in
chronic states. In the first few weeks following the outbreak in China, more than half of

the participants in one study reported the psychological impact of the pandemic and
ensuing quarantine as moderate-to-severe (Wang et al., 2020). Brooks et al. (2020)
conducted a literature review and further identified the following stressors related to
quarantine: long duration, fear of infecting others, frustration, boredom, inadequate
information, financial concerns, and stigma.
The Plan-Do-Study-Act (PDSA) model was selected to guide this project for its
focus on quality improvement (Scoville & Little, 2014). By breaking down the steps into
plan, do, study, and act, this model breaks down the thinking process into steps so that the
outcome can be evaluated, improved, and tested again (Scoville & Little, 2014). The
planning stage involved meeting with the members of the mental health clinic to
determine the scope of the project.
The increase in neuropsychiatric symptoms after COVID-19 is being established
in the literature. The long-term impact of these symptoms has yet to be seen. These
symptoms range from mood, anxiety, psychosis, and PTSD, all which could also lead to
suicidal behaviors. The impact of quarantine after diagnosis is also significant, and may
contribute to these symptoms. Veterans already have an increased incidence of mental
illness, and are a vulnerable population. Screening veterans without a history of mental
illness may improve access to care and improve health outcomes long-term.
Method
Design
This project was initially identified by the clinic lead in the mental health clinic at
the medical center after reading early reports of people developing symptoms of mental
illness after COVID-19 diagnosis. Preliminary conversations with stakeholders within the
mental health clinic established the need for further evaluation of this patient population.

There is no current process to further assesses veterans for symptoms of mental illness
after COVID-19 diagnosis. A study design was created with the assistance of the medical
center liaison for this project.
This quality improvement project was conducted utilizing a cohort design
following the PDSA model. A retrospective chart query was conducted to identify
patients with a positive COVID-19 diagnosis without a documented history of mental
illness. Data was queried from March 2020 to March 2021. The initial interview was
conducted by phone and included the veteran self-reporting responses to questions within
the screening tools. The 30 day follow up was conducted via chart review.
Setting
This project took place in the Midwest, at an urban medical center with two
campuses. This medical center provides inpatient and ambulatory care in a two-division
facility for veterans living in the Midwest and surrounding areas (U.S. Department of
Veterans Affairs, 2015). To be eligible for services at this medical center, a veteran must
provide proof of service, usually an Armed Forces Report of Transfer or Discharge (U.S.
Department of Veterans Affairs, 2015).
Sample
This purposeful sample was veterans with a positive COVID-19 diagnosis in the
project’s medical center. Veterans were identified utilizing a retrospective chart review
with the electronic medical record. Inclusion criteria was no documented history of
mental illness, male or female, ages 18 through 89, and receiving health care services at
the medical center. Exclusion criteria was age < 18 or > 89, a documented history of
mental illness, including major depressive disorder, generalized anxiety disorder, panic

disorder, adjustment disorder, post-traumatic stress disorder, schizophrenia, unspecified
psychosis, bipolar I or II disorder, suicide attempts, schizoaffective disorder, or dementia
in the electronic medical record. ICD-9 and ICD-10 codes were used to identify exclusion
criteria (Appendix B). A second review of the veteran’s face sheet in the electronic
medical record was completed to identify additional diagnoses. If no previous mental
illness was documented, the veteran was then be screened for mental illness.
Data Collection/Analysis
Data that was collected and analyzed included the following (Appendix C): the
number of COVID-19 positive veterans with no past psychiatric history who have
significant symptoms of mental illness as indicated by the Patient Health Questionnaire
(PHQ)-9, Generalized Anxiety Disorder Scale (GAD)-7, PTSD Check List (PCL)-5, The
Early Detection Primary Care Check List (PCCL) and Mini Mental Status Exam (MMS);
the number of COVID-19 positive veterans who require a mental health referral after
screening for psychiatric symptoms; the number of veterans who received mental health
care after referral at 30 days, including medication management and psychotherapy at the
medical center; and the number of veterans who received mental health care after referral
at 30 days, including medication management and psychotherapy in the community
setting.
The PHQ-9 is screening tool for depression intended for use in primary care. The
PHQ-9 has nine questions that the patient answers using a Likert scale, with one
additional question to be answered if one of the first nine questions was positive
(Kroenke et al., 2001). A score of 10- 14 indicates mild depression. A score of 15- 19
indicates moderately severe major depression, and a score greater than 20 indicates

severe major depression (Kroenke et al., 2001). A cut-off score of 10 will be utilized for
this project as this indicates mild depressive symptoms. In three recent studies, the PHQ9 performed well to identify symptoms of depression (α= .87) (Beard et al, 2015, Levis et
al., 2019 & Manea et al., 2015).
The GAD-7 is screening tool for anxiety utilized in primary care. The GAD-7 is a
7-item self-report measure. Scores between 5-9 indicate mild anxiety, 10- 14 moderate
anxiety, and scores greater than 15 severe anxiety (Spitzer et al., 2006). A cut-off score of
10 will be used for this project. This tool was recently evaluated and found to be a
psychometrically sound instrument (sensitivity 0.83 and specificity 0.84) to identify
patients with anxiety disorders (Jordan et al., 2017 & Plummer et al., 2015).
The PCCL is a 20-item tool that assesses general functioning, psychological and
social contexts, hallucinations, delusions, and disorganized speech and thinking
(Addington et al., 2015). This tool has demonstrated an 89% sensitivity and a 60%
specificity (Addington et al., 2015). A screen would be considered positive if the score
was 20 or greater or endorsement of any of the five key indicators (Addington et al., 2015
& French et al., 2012). For this project, the same criteria will be utilized.
The PCL-5 is a screening tool for PTSD for the civilian and military population. It
is a 20-item self-report that assesses a person’s response to a distressing event over the
past month (Weathers et al., 2013 & Wortman et al., 2016). In 2016, the PCL-5 was
found to be psychometrically sound (α= .91) with high internal consistency (Wortman et
al, 2016). PTSD should be considered when a person endorses a severity of at least two in
each cluster (Wortman et al., 2016), and this will be the criteria for this project.

The MMSE was originally designed as a 30-point in-person exam to measure
cognitive impairment (Tariq et al., 2006). The maximum score is 30; a score of <24 is
considered abnormal (Hunt et al., 2017). Due to the telehealth approach of this project, a
literature review was conducted to determine the validity of administering this exam via
telehealth. In a study by Ciemens et al. (2009), the traditional in-person MMSE was
compared to telehealth delivered MMSE and was found to have a 90% correlation
between the two delivery methods. Newkirk et al. (2004) corroborated this finding,
demonstrating a .88 correlation. The adapted 23-point exam will be utilized for this
project, with a score of <21 considered abnormal and prompting referral.
Potential risks for veterans include loss of confidentiality and distress from the
sensitive nature of the questions asked, with protections as outlined below. Benefits of
participation include accessing the appropriate resources for mental health care.
Participation in this quality improvement project took approximately 15 minutes of the
veteran’s time.
Participants’ data was securely saved in a password-protected folder, derived
from chart information in previous admissions. Participants medical information was
protected via a coded system and stored on a password protected limited-access medical
center server. Identifiers were coded, and the coded list kept in a separate limited-access,
password protected file (Appendix D). The linked code between data and identifiers will
be kept for 6 years after the end of the fiscal year the study was completed or as long as
bound by other federal requirements in compliance with RSC 10-1. Passwords for this
file will maintain minimum standard requirements as endorsed by the medical center for
strong passwords. Removal of access to study data will be performed for study personnel

when they are no longer part of the research team. Descriptive statistics will be used for
analysis.
Approval Process
The approval process began by determining if this was a QI/QA project through
the medical center Research Office. The medical center ACOS determined this project
was quality improvement. A further review of the project was conducted by the medical
center institutional review board, and was determined to be a quality improvement
project. This project was also reviewed by the university institutional review board and
was acknowledged as a quality improvement project.
Procedures
A query report was utilized to identify veterans with a positive COVID-19
diagnosis. At the time of this study, there were over 1500 veterans with a positive
COVID-19 diagnosis. Once identified, a query report determined if the veteran has been
previously diagnosed with a mental illness. Veterans were contacted in April 2021 until a
sample size of 50 was reached.
The veteran with no previous mental illness was then screened via telephone.
Verbal consent (Appendix E) was obtained at the beginning of the conversation to alert
the veteran that assessment questions contained sensitive information. The Doximity
smartphone application was utilized to protect veteran and investigator privacy. The
number was linked to the medical center liaison’s office phone number, where secure
messages can be left. Three attempts were made to contact the veteran. After the first
attempt, a voice mail message was left stating when the next call will be made or to
return the phone call (Appendix F). If a return call was not received after one week, a

second attempt was made. The same applied for the third phone call. If after three
attempts to reach the veteran, contact was not made, then no additional attempts occurred.
Initially, the veterans were screened for symptoms of depression and anxiety
using the PHQ-9 and GAD-7. Further assessment for PTSD using the PCL-5 and
psychosis using the PCCL was completed. To complete the screening, a MMSE was
performed. Once the screening was completed and a positive value on any of the five
tools was found, the veteran determined if he/she is amenable to a mental health clinic
referral for further care (Figure 1). If so, the veteran was referred to the mental health
clinic for further care and a referral was placed in the electronic medical record. If the
veteran declined mental health referral, the number for the medical center crisis line was
given to the veteran. If the PHQ-9 or PCL- 5 indicated suicidality during the assessment,
a licensed independent practitioner at the mental health clinic was available to assess the
veteran within 24 hours per the medical center standard operating procedure. The study
team planned to collaborate with local Psychiatric Emergency Services and/ or the
participant’s primary care provider to develop a treatment plan that adequately addresses
the suicidal thoughts or behavior if identified. A note (Appendix G) was placed in the
veteran’s electronic medical record that screening was completed, along with the results.
The note was coded with diagnostic code Z13.9 (encounter for screening, unspecified)
and procedure code 96127 (brief behavioral assessment). This note was co-signed by the
medical center liaison for this project.
Once the mental health clinic received the referral, an appointment was made for
a full mental health intake assessment and initiation of an appropriate treatment plan.

After 30 days, the medical record was reviewed to validate if a mental health clinical
appointment had been made, and what treatment plan was initiated.
Figure 1
Process for Mental Health Clinic Referral

Results
When this project was conceived, there were approximately 300 veterans in the
medical center with a positive COVID-19 diagnosis. At the time of project
implementation, 1,513 veterans in the medical center had tested positive for COVID-19.
From this data, 216 charts were reviewed utilizing a random number generator (Figure 2).
In this initial chart review, 127 of the veterans were exclude because of a previous mental
health diagnosis, representing 59% of the veterans in the randomized group selected for
screening for inclusion in the project.
Figure 2
CONSORT Flowchart of Participants

When contact was made, each phone call lasted between 10- 20 minutes,
depending on veteran responses. Three veterans had positive screens, and two had mental
health clinic referrals placed. One veteran declined the mental health clinic referral and
the appropriate resources were provided to the patient. One patient was assessed by the
mental health clinic and a treatment plan was implemented. This veteran opted for
individual psychotherapy at the medical center, and deferred medication management.
One veteran did not return the phone calls from the mental health clinic to schedule an
appointment. This resulted in a 6% positivity rate for new symptoms of mental illness for
this project.
In this sample, 94% (47) of the veterans were male; 6% (3) veterans were female.
The average age was 63.1 years (range 30- 88). The average time since COVID-19
diagnosis was 140.48 days (range 51- 178). The average score of each instrument is
shown in Table 1. The PHQ-9 assesses for depressive symptoms and a score of 10- 14
indicates mild depression. The mean value of participants was 2.34 (range 0- 13). The
GAD-7 assesses for anxiety; scores between 10- 14 indicate moderate anxiety. The mean
value of participants was 1.76 (range 0- 15). The PCCL is a tool used to assess for
symptoms of psychosis; a score of 20 or greater is considered positive. The mean value of
participants was 1.44 (range 0- 14). The PCL-5 is tool to assess for PTSD; the PCL-5 is
considered positive when a person endorses a severity of 2 in each cluster. The mean
value of participants was 1.44 (range 0- 14). There were no participants who endorsed a
severity of 2 each cluster that met the criteria for PTSD. The MMSE was designed to
measure cognitive impairment and for this project, the tele MMSE was utilized. The max

score is 23; a score less than 21 was considered positive. The mean value for participants
was 22.5 (range 11- 23).
Table 1
Instrument Analysis
Scale

Clinical

Positive

Mean

Standard

Cut Off

Screens

Value

Deviation

Range

Score
PHQ-9

10

3

2.34

3.05

0- 13

GAD- 7

10

2

1.76

3.04

0- 15

PCCL

20

0

1.44

3.15

0- 14

PCL- 5

6

0

1.04

2.83

0-13

TMMS

20

2

22.5

1.80

11-23

Discussion
The most recent statistics show a 12.84% estimated incidence of developing a
psychiatric diagnosis for the first time after COVID-19 diagnosis (Taquet et al., 2021).
That study had a sample size of 236,379 patients (Taquet et al., 2021). This quality
improvement project found 6% of veterans with symptoms of mental illness in sample
size of 50. This number may be lower than expected because the project population has
an overall higher incidence of mental illness. Additionally, the veterans that screened
positive were all greater than 100 days since their COVID-19 diagnosis; this may be
useful for further use. Although in place, no one screened needed an immediate referral to
the mental health clinic.

Making phone contact with veterans was easier than anticipated. The use of the
Doximity smart phone application may have increased the likelihood that the phone was
answered; the caller ID showed the project site. Thirty-three veterans (66%) answered the
phone on the first attempt. Eleven veterans answered the phone on the second attempt
and six answered on the third attempt.
Many veterans screened during this project expressed gratitude for the contact and
screening. Several veterans shared how appreciative they were for the phone call, and
how they felt valued by the medical center. One veteran further elaborated that this
screening may present an opportunity for veterans to speak more candidly about their
mental health in the setting of COVID-19 versus their military experience. The six
veterans that declined to participate indicated there was nothing wrong with their mental
health and did not feel the need to participate.
Limitations of this project include a small, mostly male sample size. Screening for
depression, anxiety, psychosis, PTSD, and dementia was also time intensive. Initially,
this project sought to identify veterans experiencing depression and anxiety. During the
literature review, an increased incidence of psychosis, PTSD, and neurocognitive
symptoms was also identified. This evidence suggested further screening may be
beneficial, and the PCCL, PCL-5, and TMMS were included in the screening questions.
The addition of these screening tools increased the length of time for screening. While
time intensive, it was important to include these tools for this small, more vulnerable
population. In analyzing the data, it was observed that no one screened positive for
psychosis, PTSD, or dementia without having a positive screen for depression or anxiety.

It is beyond the scope of this quality improvement project to determine if the 59%
of COVID-19 positive veterans with an established history of mental illness have
experienced an exacerbation of symptoms since their diagnosis. This does demonstrate
the importance of screening this vulnerable population for mental illness since veterans
have higher baseline of mental illness than the general population.
Recommendations
If beneficial for veterans and the mental health clinic, as determined by the mental
health clinic leadership team, a policy or practice guideline for screening in veterans
positive for COVID-19 with no previous mental illness will be established for continued
use. Based upon the results of this project, it is recommended that initial screening of
veterans utilizing the PHQ-9 and GAD-7 for depression and anxiety. Screening for
psychosis, PTSD, and dementia would only occur if the veteran screened positive for
depression or anxiety. It was also noted that the veterans who did screen positive did so
100 days or more after their COVID-19 diagnosis; this may be a useful number to flag
patient’s charts for screening. This is also consistent with data found in the literature
review. This specific screening after COVID-19 diagnosis may also identify veterans
with symptoms who may not have verbalized them before. Given the incidence of mental
illness after COVID-19 diagnosis, it may be prudent to screen the veterans that were not
included in this quality improvement project. The veterans included in this project did
not have a history of mental illness; screening did not occur with the veterans with an
established history of mental illness for exacerbation. Additional studies may be
beneficial to identify exacerbations of mental illness after COVID-19 diagnosis.

Conclusion
This quality improvement project highlights the importance of screening the
veteran population for mental illness after a diagnosis of COVID-19. There was an
increase in the number of COVID-19 cases from 300 to over 1,500 in a little over six
months. This shows the importance of screening veterans efficiently after their COVID19 diagnosis. The project site currently has a process in place to contact veterans after
COVID-19 diagnosis to assess their physical health; adding the PHQ-9 and GAD-7 to
this phone call would be beneficial. Military veterans do have a higher incidence of
mental illness; continued screening after COVID-19 diagnosis could continue to identify
vulnerabilities in an already vulnerable population.
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Appendix B

ICD-9 and ICD-10 Codes for Exclusion Criteria
Diagnosis
Major depressive disorder
Generalized anxiety disorder
Panic disorder
Obsessive-compulsive disorder
Adjustment disorder
Post-traumatic stress disorder
Schizophrenia
Unspecified psychosis
Bipolar I disorder
Bipolar II disorder
Suicide attempts
Schizoaffective disorder
Dementia

ICD-9
296.2
300.02
300.01
300.3
309
309.81
295.0
298.9
296.0
296.8
950.9
295.7
290

ICD-10
F33
F41.1
F41.0
F42.9
F43.20
F43.10
F20.9
F29
F31
F31.81
Z91.5
F25.9
F30.91

Appendix C
Screening Tool for Mental Illness after COVID-19 Diagnosis
Identification Code:

Age/Gender:

Over the last 2 weeks:

Little interest or pleasure in doing things
PHQ9
Feeling down, depressed or hopeless
Trouble falling asleep, staying asleep, or
sleeping too much
Feeling tired or have little energy
Poor appetite or overeating
Feeling bad about yourself
Trouble concentrating on things
Moving or speaking too slowly, or the opposite,
being fidgety or restless
Thoughts that you would be better off dead
Column Totals
Added Totals
If you checked off any problems, how difficult
have these problems made it for you to do your
work, take care of things at home, or get along
with other people?

Feeling nervous, anxious, or on edge
GAD7
Not being able to stop or control worrying
Worrying too much about different things
Trouble relaxing
Being so restless that it’s hard to sit still
Becoming easily annoyed or irritable
Feeling of afraid as if something awful might
happen
Column Totals
Added Totals
If you checked off any problems, how difficult
have these problems made it for you to do your
work, take care of things at home, or get along
with other people?

Spending more time alone
Arguing with family or friends
The family is concerned
Excess use of alcohol
Use of street drugs (including cannabis)
Sleep difficulties
Poor appetite
Depressive mood
Poor concentration
Restlessness
Tension and nervousness
Less pleasure from things
Feeling people are watching you

PCCL

Date of Diagnosis:

Not at
All

Severa
l Days

More Than
Half Days

0
0
0

1
1
1

2
2
2

Nearl
y
Ever
y
Day
3
3
3

0
0
0
0
0

1
1
1
1
1

2
2
2
2
2

3
3
3
3
3

0

1

2

3

Not
difficult
at all

Some
what
difficu
lt

Very
difficult

Extre
mely
diffic
ult

0
0
0
0
0
0
0

1
1
1
1
1
1
1

2
2
2
2
2
2
2

3
3
3
3
3
3
3

Not
difficult
at all

Some
what
difficu
lt

Very
difficult

Extre
mely
diffic
ult

Yes
1
1
1
1
1
2
2
2
2
2
2
2
3

No

Feeling or hearing things that others cannot
Ideas of reference
Odd beliefs
Odd manner of talking or speech
Inappropriate affect
Odd behavior or appearance
First-degree family history of psychosis plus
increased stress or deterioration of functioning

3
5
5
5
5
5
5
Total Score
Not at
all

Repeated, disturbing, and unwanted memories of
the
stressful experience?
Repeated, disturbing dreams of the stressful
experience?
Suddenly feeling or acting as if the stressful
experience were actually happening again (as if
you were actually back there
reliving it)?
Feeling very upset when something reminded
you of the
stressful experience?
Having strong physical reactions when
something reminded
you of the stressful experience (for example,
heart
pounding, trouble breathing, sweating)?
Avoiding memories, thoughts, or feelings related
to the
stressful experience?
Avoiding external reminders of the stressful
experience (for
example, people, places, conversations,
activities, objects, or
situations)?
Trouble remembering important parts of the
stressful
experience?
Having strong negative beliefs about yourself,
other people,
or the world (for example, having thoughts such
as: I am
bad, there is something seriously wrong with me,
no one can be trusted; the world is completely
dangerous)?
Blaming yourself or someone else for the
stressful
experience or what happened after it?
Having strong negative feelings such as fear,
horror, anger,
guilt, or shame?
Loss of interest in activities that you used to
enjoy?
Feeling distant or cut off from other people?
Trouble experiencing positive feelings (for
example, being
unable to feel happiness or have loving feelings
for people

PCL-5

Moderately

Quite
a bit

Extre
mely

0

A
little
bit
1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0
0

1
1

2
2

3
3

4
4

close to you)?
Irritable behavior, angry outbursts, or acting
aggressively?
Taking too many risks or doing things that could
cause you
harm?
Being “super alert” or watchful or on guard?
Feeling jumpy or easily startled?
Having difficulty concentrating?
Trouble falling or staying asleep?
Total Score

“What is the year? Season? Date? Day of the
week? Month?”
“Where are we now: State? County? Town/city?
Hospital? Floor?”
The examiner names three unrelated objects
clearly and slowly, then asks the patient to name
all three of them. The patient’s response issued
for scoring. The examiner repeats them until
patient learns all of them, if possible.
Number of trials: ___________
“I would like you to count backward from 100
by sevens.” (93, 86, 79,72, 65, …) Stop after five
answers.
Alternative: “Spell WORLD backwards.” (D-LR-O-W)
“Earlier I told you the names of three things. Can
you tell me what those were?”
“Repeat the phrase: ‘No ifs, ands, or buts.’”
“Make up and write a sentence about anything.”
(This sentence must contain a noun and a verb.)
Total Score

TMMSE

0

1

2

3

4

0

1

2

3

4

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3

4
4
4
4

Patient’
s Score

Max
Score
5
5
3

5

3
1
1

Score
PHQ-9
GAD-7
PCCL
PCL-5
TMMSE
Yes
Veteran agreeable to mental health referral
Appropriate for Jefferson Barracks
Need to be seen at John Cochran
Preference for community setting
Consult placed in CPRS

No

Appendix D
Data Collection Tool

Vet
Phone
Phone
Phone
Number Attempt Attempt Attempt
#1
#2
#3

Results of
Screen

Referral to
Mental Health
Clinic
Yes/No

30 Day
Follow
Up?
Yes/No

Appendix E
Informed Consent Verbal Script
You are invited to participate in a research study conducted by Brittania Phillips and
Anne Thatcher. The purpose of this research is identify veterans who may be at risk for
mental illness and refer them to the appropriate care.
You are consenting to participate in a quality improvement project about the development
of mental illness symptoms after COVID-19 diagnosis. There is evidence that suggest
that people without a history of mental illness are developing symptoms of mental illness
after contracting COVID-19, including symptoms of depression, anxiety, PTSD, and
psychosis. Your participation in this voluntary. If you choose, you will be screened for
depression, anxiety, PTSD, psychosis, and neurocognitive disorders. If these symptoms
are present, then you will receive a referral to the mental health clinic at the VA or a
communicatory resource. Reasonable, foreseeable risks or discomforts may include the
sensitivity of questions asked. Reasonable, expected benefits include accessing
appropriate care for the symptoms you may be experiencing.
Your participation will involve answering verbal questions using standardized assessment
tools over the phone. This will take approximately 15 minutes. You were identified to be
included based upon your COVID-19 diagnosis and past medical history.
Approximately 100 veterans may be involved in this research at the St. Louis VA.
There are no known risks associated with this research (other than the potential for mild
boredom or fatigue). The possible benefits to you from this research are accessing mental
health care for symptoms you are experiencing.
Your participation is voluntary and you may choose not to participate in this study or
withdraw your consent at any time. You will NOT be penalized in any way should you
choose not to participate or withdraw.
We will do everything we can to protect your privacy. As part of this effort, your identity
will not be revealed in any publication that may result from this study. In rare instances, a
researcher's study must undergo an audit or program evaluation by an oversight agency
(such as the Office for Human Research Protection) that would lead to disclosure of your
data as well as any other information collected by the researcher.
Federal agencies such as the Office for Human Research Protection (OHRP), the
Government Accounting Office (GAO), Office of Research Oversight (ORO), St. Louis
VAHCS Institutional Review Board, VA Audit Committees and accrediting agencies will
have access to the records and records are subject to audit or inspection by a funding
agency or sponsor. A copy of this consent form will be filed in your medical records, and
for your safety, your medical records may be flagged to alert other healthcare providers
that you are participating in the study. Your medical records will include a note that you
have consented to participate in the study.

As a VA study participant, the VA (not you or your insurance) will provide necessary
medical treatment should you be injured by being in this study. You will be treated for
the injury at no cost to you. This care may be provided by the VASTLHCS or
arrangements may be made for contracted care at another facility. You have not released
this institution from liability for negligence. In case of research related injury resulting
from this study, you should contact your study team. If you have questions about
compensation and medical treatment for any study related injuries, you can call the
Research & Education Service at VSATLHCS at 314-289-6333
If you have any questions or concerns regarding this study, or if any problems arise, you
may call the Investigator, Brittania Phillips or the Faculty Advisor, Anne Thatcher at
(314) 652-4100 x64656. You may also ask questions or state concerns regarding your
rights as a research participant to the Office of Research at the University of Missouri- St.
Louis, at (314) 516-5897.

Appendix F
Voicemail Script

Principal Investigator:
Hello, this is [insert name], calling from the St. Louis VA John Cochran. I was calling to
see how your health has been, and to ask you a few follow up questions. I will attempt to
call you again on [specific date] or you may reach me at (314) 652-4100 x 53313. If I do
not answer, please leave a message and I will return your call.

Appendix G
Note Template for CPRS (EMR)
Veteran Name
The above veteran was screened for symptoms of mental illness using the PHQ-9, GAD7, PCL-5, PCCL, and MMSE. This screening was conducted as part of a quality
improvement project through the mental health services.
PHQ-9
Little interest or pleasure in doing things:
Feeling down, depressed or hopeless:
Trouble falling asleep, staying asleep, or sleeping too much:
Feeling tired or have little energy:
Poor appetite or overeating:
Feeling bad about yourself:
Trouble concentrating on things:
Moving or speaking too slowly, or the opposite, being fidgety or restless:
Thoughts that you would be better off dead:
If you checked off any problems, how difficult have these problems made it for
you to do your work, take care of things at home, or get along with other people?
PHQ-9 results:
---------GAD-7
Feeling nervous, anxious, or on edge:
Not being able to stop or control worrying:
Worrying too much about different things:
Trouble relaxing:
Being so restless that it’s hard to sit still:
Becoming easily annoyed or irritable:
Feeling of afraid as if something awful might happen:
If you checked off any problems, how difficult have these problems made it for
you to do your work, take care of things at home, or get along with other people:

GAD-7 results:
---------PCL-5
Repeated, disturbing, and unwanted memories of the stressful experience:
Repeated, disturbing dreams of the stressful experience:
Suddenly feeling or acting as if the stressful experience were actually happening
again (as if you were actually back there reliving it):
Feeling very upset when something reminded you of the stressful experience:
Having strong physical reactions when something reminded you of the stressful
experience (for example, heart pounding, trouble breathing, sweating):
Avoiding memories, thoughts, or feelings related to the stressful experience:
Avoiding external reminders of the stressful experience (for example, people,
places, conversations, activities, objects, or situations):
Trouble remembering important parts of the stressful experience:
Having strong negative beliefs about yourself, other people, or the world (for
example, having thoughts such as: I am bad, there is something seriously wrong
with me, no one can be trusted; the world is completely dangerous):
Blaming yourself or someone else for the stressful experience or what happened
after it:
Having strong negative feelings such as fear, horror, anger, guilt, or shame:
Loss of interest in activities that you used to enjoy:
Feeling distant or cut off from other people:
Trouble experiencing positive feelings (for example, being unable to feel
happiness or have loving feelings for people close to you):
Irritable behavior, angry outbursts, or acting aggressively:
Taking too many risks or doing things that could cause you harm:
Being “super alert” or watchful or on guard:
Feeling jumpy or easily startled:
Having difficulty concentrating:
Trouble falling or staying asleep:
PCL-5 results:

---------PCCL
Spending more time alone:
Arguing with family or friends:
The family is concerned:
Excess use of alcohol:
Use of street drugs (including cannabis):
Sleep difficulties:
Poor appetite:
Depressive mood:
Poor concentration:
Restlessness:
Tension and nervousness:
Less pleasure from things:
Feeling people are watching you:
Feeling or hearing things that others cannot:
Ideas of reference:
Odd beliefs:
Odd manner of talking or speech:
Inappropriate affect:
Odd behavior or appearance:
First-degree family history of psychosis plus increased stress or deterioration of
functioning:
PCCL results:
---------MMSE
“What is the year? Season? Date? Day of the week? Month?”
“Where are we now: State? County? Town/city? Hospital? Floor?”

The examiner names three unrelated objects clearly and slowly, then asks the
patient to name all three of them. The patient’s response issued for scoring. The
examiner repeats them until patient learns all of them, if possible.
Number of trials: ___________
“I would like you to count backward from 100 by sevens.” (93, 86, 79,72, 65, …)
Stop after five answers.
Alternative: “Spell WORLD backwards.” (D-L-R-O-W)
“Earlier I told you the names of three things. Can you tell me what those were?”
“Repeat the phrase: ‘No ifs, ands, or buts.’”
“Make up and write a sentence about anything.” (This sentence must contain a
noun and a verb.)
MMSE results:

The veteran was/was not amenable to a mental health clinic referral. A consult has been
placed if appropriate. The veteran has been supplied with the number for the crisis line
and resources provided.

